Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals-Reference-Cited by-同舟云学术

Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals

Published:2019-09-06 Issue:4 Volume:76 Page:190-194
ISSN:0967-4845
Container-title:British Journal of Biomedical Science
language:en
Short-container-title:British Journal of Biomedical Science

Author:

Łucejko M¹,Tomasiewicz K²^ORCID,Olczak A³,Tudrujek-Zdunek M²^ORCID,Halota W³^ORCID,Jelski W⁴^ORCID,Donica H⁵^ORCID,Krintus M⁶^ORCID,Mroczko B⁴^ORCID,Flisiak R¹^ORCID

Affiliation:

1. Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland

2. Department of Infectious Diseases and Hepatology, Division of Laboratory Diagnostics, Medical University of Lublin, Lublin, Poland

3. Department of Infectious Diseases and Hepatology, Nicolaus Copernicus University, Torun, Poland

4. Department of Biochemical Diagnostics, Medical University of Bialystok, Bialystok, Poland

5. Department of Biochemical Diagnostics, Division of Laboratory Diagnostics, Medical University of Lublin, Lublin, Poland

6. Department of Laboratory Medicine, Nicolaus Copernicus University, Torun, Poland

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Biochemistry (medical),Microbiology (medical),Clinical Biochemistry,Immunology,Microbiology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09674845.2019.1654790

Reference31 articles.

1. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

2. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

3. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

4. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection

5. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic performance of hepatitis C core antigen assay to identify active infections: A systematic review and meta‐analysis;Reviews in Medical Virology;2023-02-22

2. Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023;Clinical and Experimental Hepatology;2023

3. HCV Core-antigen Assay as an Effective Alternative to HCV RNA Quantification in Patients With Hepatitis C;In Vivo;2023

4. Meta‐analysis: diagnostic accuracy of hepatitis C core antigen detection during therapy with direct‐acting antivirals;Alimentary Pharmacology & Therapeutics;2022-08-28

5. The utility of HCV core antigen for evaluation of viremia at 48 weeks posttreatment with direct‐acting antivirals;Advances in Digestive Medicine;2022-04-26